1. Home
  2. FCNCP vs MIRM Comparison

FCNCP vs MIRM Comparison

Compare FCNCP & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Citizens BancShares Inc.

FCNCP

First Citizens BancShares Inc.

N/A

Current Price

$20.18

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

N/A

Current Price

$68.57

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCNCP
MIRM
Founded
N/A
2018
Country
United States
United States
Employees
17475
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FCNCP
MIRM
Price
$20.18
$68.57
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$88.36
AVG Volume (30 Days)
N/A
602.6K
Earning Date
N/A
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
N/A
$19.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.66
52 Week Low
N/A
$36.88
52 Week High
N/A
$78.55

Technical Indicators

Market Signals
Indicator
FCNCP
MIRM
Relative Strength Index (RSI) 22.99 49.52
Support Level $20.67 $63.23
Resistance Level $21.21 $66.77
Average True Range (ATR) 0.39 3.03
MACD -0.13 -0.19
Stochastic Oscillator 1.61 45.94

Price Performance

Historical Comparison
FCNCP
MIRM

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: